This review outlines the fundamental strategies that are required to develop antibody therapies.Dr Jyotsna ShuklaDr Rajni SharmaA.K.ShuklaDr Pooja Shukla
Article Open access 03 April 2025 Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response Article Open access 19 September 2022 References Howlader, N., et al. (eds) SEER Cancer Statistics Review, 1975–2013. National Cancer Institute: Surveillance Epidemiology, and...
Article CAS PubMed Google Scholar Taylor, D. M. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet. J. 159, 10–17 (2000). Article CAS PubMed Google Scholar Aguzzi, A. Neuro-immune connection in spread of prions in the body? Lancet 349, 742–743 (1997). ...
Lehrnbecher, T., Foster, C.B., Zhu, S., Leitman, S.F., Goldin, L.R., Huppi, K., et al. (1999). Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood...
and creating combined systemic therapy options incorporating conventional treatments such as chemotherapy and endocrine therapy. This review will focus on the current role and future directions of many of these immunotherapies in breast cancer, as well as highlighting clinical trials that are investigating...
(NSCLC). Additionally, the review also explores the implication of nanomedicine in lung cancer immunotherapy as well as the combinatorial application of traditional therapy along with immunotherapy regimens. Finally, ongoing clinical trials, significant obstacles, and the future outlook of this treatment ...
Waller LP, Deshpande V, Pyrsopoulos N (2015) Hepatocellular carcinoma: a comprehensive review. World J Hepatol 7(26):2648–2663. doi:10.4254/wjh.v7.i26.2648 Article PubMed PubMed Central Google Scholar Greten TF, Duffy AG, Korangy F (2013) Hepatocellular carcinoma from an immunologic persp...
Sarah Klein, PhD, Associate Director, Multiplex Assay Development at Cell Signaling Technology, contributed to the writing and review of this article.
Immune deserts in head and neck squamous cell carcinoma: a review of challenges and opportunities for modulating the tumor immune microenvironment Oral Oncol., 120 (2021), Article 105420 View PDFView articleView in ScopusGoogle Scholar [8] C. Badoual, S. Hans, J. Rodriguez, S. Peyrard, C....
This review article discusses the current status of CAR T and NK cell therapies and their limitations, followed by emerging CAR macrophage therapy. Table 1 Current FDA approvals of CAR T therapies Full size table Fig. 1 Timeline of CAR T therapy FDA approvals Full size image Main text CAR ...